VICTORIA HOGG: Open Payments
NPI 1134723307 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,276 in 63 payments from 13 companies in 2025. Trend: 2023 $508 · 2024 $827 · 2025 $1,276
Food & beverage: $1,276
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 19 | $542 |
| ABBVIE INC. | 18 | $255 |
| Otsuka America Pharmaceutical, Inc. | 11 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Lundbeck LLC | 2 | $35 |
| Alkermes, Inc. | 2 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Noven Therapeutics, LLC | 1 | $25 |
| Braeburn Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
Products named: Auvelity, VRAYLAR, REXULTI, CAPLYTA, ARISTADA, INGREZZA, Secuado, BRIXADI.
Industry payments across LA — which companies pay providers there.
